Literature DB >> 22371902

Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy.

Federico Pea1, Piergiorgio Cojutti, Alberto Pagotto, Francesco Cristini, Mario Furlanut, Pierluigi Viale.   

Abstract

Cerebral nocardiosis is a severe infection that carries the highest mortality rate among all bacterial cerebral abscesses. We report on a case in an immunocompromised patient which was successfully treated with unexpectedly low doses of linezolid. Therapeutic drug monitoring was very helpful in highlighting issues of poor compliance and of drug-drug interactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22371902      PMCID: PMC3370739          DOI: 10.1128/AAC.00135-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient.

Authors:  Federico Pea; Luigia Scudeller; Manuela Lugano; Umberto Baccarani; Federica Pavan; Marcello Tavio; Mario Furlanut; Giorgio Della Rocca; Fabrizio Bresadola; Pierluigi Viale
Journal:  Clin Infect Dis       Date:  2006-02-01       Impact factor: 9.079

2.  In vitro activities of linezolid against multiple Nocardia species.

Authors:  B A Brown-Elliott; S C Ward; C J Crist; L B Mann; R W Wilson; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.

Authors:  Yasuhiro Tsuji; Yoichi Hiraki; Kana Matsumoto; Akiko Mizoguchi; Tsutomu Kobayashi; Shinichi Sadoh; Kunihiko Morita; Hidetoshi Kamimura; Yoshiharu Karube
Journal:  J Infect Chemother       Date:  2010-06-26       Impact factor: 2.211

4.  Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.

Authors:  Pavlos Myrianthefs; Sophia L Markantonis; Konstantinos Vlachos; Maria Anagnostaki; Eleni Boutzouka; Dimitris Panidis; Georgios Baltopoulos
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

5.  Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.

Authors:  M Katoh; M Nakajima; H Yamazaki; T Yokoi
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

6.  Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein.

Authors:  Iouri Bachmakov; Ulrike Werner; Beate Endress; Daniel Auge; Martin F Fromm
Journal:  Fundam Clin Pharmacol       Date:  2006-06       Impact factor: 2.748

7.  Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.

Authors:  C Pauli-Magnus; S Rekersbrink; U Klotz; M F Fromm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-12       Impact factor: 3.000

Review 8.  Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.

Authors:  Barbara A Brown-Elliott; June M Brown; Patricia S Conville; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

9.  Clinical experience with linezolid for the treatment of nocardia infection.

Authors:  Edina H Moylett; Susan E Pacheco; Barbara A Brown-Elliott; Tracy R Perry; E Stephen Buescher; Mary C Birmingham; Jerome J Schentag; Joseph F Gimbel; Aaron Apodaca; Margot A Schwartz; Robert M Rakita; Richard J Wallace
Journal:  Clin Infect Dis       Date:  2003-01-13       Impact factor: 9.079

10.  Human nocardiosis in northern Italy from 1982 to 1992. Northern Italy Collaborative Group on Nocardiosis.

Authors:  C Farina; P Boiron; A Goglio; F Provost
Journal:  Scand J Infect Dis       Date:  1995
View more
  7 in total

1.  A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?

Authors:  Federico Pea; Piergiorgio Cojutti; Lucia Dose; Massimo Baraldo
Journal:  Br J Clin Pharmacol       Date:  2015-12-05       Impact factor: 4.335

2.  Successful treatment of multifoci nocardial brain abscesses: a case report and literature review.

Authors:  Qingsheng Xu; Renya Zhan; Yiping Feng; Jiajia Chen
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 3.  How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?

Authors:  Gloria Wong; Fekade Bruck Sime; Jeffrey Lipman; Jason A Roberts
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.090

4.  Safety and Outcomes of Linezolid Use for Nocardiosis.

Authors:  Natalie Davidson; Matthew J Grigg; Sarah L Mcguinness; Robert J Baird; Nicholas M Anstey
Journal:  Open Forum Infect Dis       Date:  2020-03-16       Impact factor: 3.835

5.  Clinical Characteristics and Treatment Outcome of Central Nervous System Nocardiosis: A Systematic Review of Reported Cases.

Authors:  Durga Shankar Meena; Deepak Kumar; Gopal Krishana Bohra; Naresh Midha; Mahendra Kumar Garg
Journal:  Med Princ Pract       Date:  2022-06-14       Impact factor: 2.132

6.  Nocardiosis: risk factors, clinical characteristics and outcome.

Authors:  Ilad Alavi Darazam; Masoud Shamaei; Mandana Mobarhan; Shahin Ghasemi; Payam Tabarsi; Masoud Motavasseli; Davood Mansouri
Journal:  Iran Red Crescent Med J       Date:  2013-05-05       Impact factor: 0.611

7.  Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice.

Authors:  Milo Gatti; Simona Barnini; Fabio Guarracino; Eva Maria Parisio; Michele Spinicci; Bruno Viaggi; Sara D'Arienzo; Silvia Forni; Angelo Galano; Fabrizio Gemmi
Journal:  Antibiotics (Basel)       Date:  2022-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.